Stock screener

SRZN

Conviction 86HealthcareScan · Thu, Sep 24, 2026

Surrozen, Inc./DE (SRZN) closed at $33.65 (+108.20%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 77, RS Rating 98, -1.4% from its 52-week high, +56.1% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

SRZN$33.65+108.20%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 603K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Surrozen, Inc./DEBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.surrozen.com ↗
Price33.65
Change+108.20%
Gap+88.12%
Rel volume33.87×
Avg volume486.56K
Avg $ vol13.97M
SMA 2020.38
SMA 5021.70
SMA 20024.32
Price vs 50+55.06%
Price vs 200+38.35%
MA stackmixed
50/200 cross—
Supertrendup · 23.05
RSI (14)77
MACD hist0.82
MACD crossbull · 0d
Stoch %K / %D89 / 35
ADX (14)33
+DI / −DI53 / 13
RSI divergence—
MACD divergence—
ATR %8.06%
ADR %7.45%
52w high34.13
52w low11.56
From 52w high-1.42%
Above 52w low+191.05%
New 52w highNo
SqueezeOff
Bollinger width77.20%
%B1.34
Donchian pos88.77%
Donchian high35.86
Donchian low16.14
AVWAP (52w high)32.93
vs AVWAP high+2.17%
AVWAP (52w low)24.63
vs AVWAP low+36.60%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d33.87×
Avg vol (14d)603K
Avg vol (20d)486.56K
Avg $ vol (20d)13.97M
Market cap395.45M
RS Rating98 / 99
RS 3m (vs SPY)+32.72%
RS 6m (vs SPY)+11.89%
RS line new highYes
Trend template7/8
Technical rank92.9
1 week+98.61%
1 month+44.03%
3 months+37.21%
6 months+28.71%
1 year+178.52%
YTD+56.13%
P/E-1.63
P/B-1.81
P/S113.73
P/FCF-13.02
EPS-32.37
Div yield—
ROE110.68%
ROA-209.35%
Debt/Eq—
Current12.14
EV/EBITDA-7.06
Gross margin—
Net margin—
Rev growth-67.37%
EPS growth-280.76%
Price target45.00
Target upside33.75%
Analyst ratingBuy
Institutional107.03%
Ent. value293.41M
Revenue5M
Net income50.18M
Gross profit—
Free cash flow-30.37M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out11.61M
Employees44
ListedThu, Aug 12, 2021
Free float4.11M
Float %47.9%
Short interest1.45M
Days to cover7.7d
Short volume63.2%
Squeeze score95 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.41 vs −$1.34
Last surprise+69.4% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank92.9 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance26.17
Support17.42
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SRZN

All disclosures →
No recent disclosed trades by Congress in SRZN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SRZN · open-market 3 sells

InsiderSideShares
Kutzkey Tim
Director · Option (right to buy) · 2026-05-13
Grant5.55K
Haak-Frendscho Mary
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
Rothenberg Mace
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
Berkenblit Anna
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
CHAI CHRISTOPHER Y
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
WOODHOUSE DAVID J
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
BJERKHOLT ERIC
Director · Director Stock Option (right to buy) · 2026-05-13
Grant5.55K
Williams Charles O
Chief Operating Officer · Common Stock · 2026-05-04
Sell2.04K
Parker Craig C
Chief Executive Officer · Common Stock · 2026-05-04
Sell4.52K
Li Yang
Exec. Vice President, Research · Common Stock · 2026-05-04
Sell1.58K

SEC filings

EDGAR filings in SRZN · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.